Sangamo Therapeutics (SGMOQ) Other Working Capital Changes (2010 - 2025)

Sangamo Therapeutics' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$352000.0 for Q4 2025.

• On a quarterly basis, Other Working Capital Changes rose 76.5% year-over-year to -$352000.0 in Q4 2025; TTM through Dec 2025 was -$352000.0, a 93.69% increase from a year earlier, with the FY2025 full-year figure at -$352000.0, up 93.69% from the prior year.
• Other Working Capital Changes eased to -$352000.0 in Q4 2025 per SGMOQ's latest filing, from $2.3 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $4.8 million in Q2 2022 and bottomed at -$6.2 million in Q1 2023.
• The 5-year median for Other Working Capital Changes is $532000.0 (2023), against an average of -$169300.0.
• Across the five-year window, Other Working Capital Changes sank 6478.95% in 2023 and surged 279.67% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$81.0 million in 2021, then dropped by 8.72% to -$88.0 million in 2022, then tumbled by 78.82% to -$157.4 million in 2023, then jumped by 99.05% to -$1.5 million in 2024, then surged by 76.5% to -$352000.0 in 2025.
• Per Business Quant, the three latest SGMOQ Other Working Capital Changes figures stand at -$352000.0 (Q4 2025), $2.3 million (Q3 2025), and -$1.0 million (Q2 2025).